New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma

Today, it is difficult to overestimate the new directions in the pharmacotherapy of peripheral T-cell lymphomas (PTCL): immunotherapy, including adoptive, targeted therapy and chemotherapy. However, there are few biomarkers that predict response to therapy. A big problem is patients with refractory...

Full description

Saved in:
Bibliographic Details
Main Authors: M. А. Sorokina, A. V. Rakhteenko, T. R. Grishina
Format: Article
Language:Russian
Published: IRBIS LLC 2023-07-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/807
Tags: Add Tag
No Tags, Be the first to tag this record!